<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>cc1030</ui>
   <ji>CCJ</ji>
   <fm>
      <dochead>Meeting abstract</dochead>
      <bibl>
         <title>
            <p>Suppression of interleukin-8 and myeloperoxidase production in the cerebrovascular bed during repeated deep hypothermic circulatory arrest</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Kuzumi</snm>
               <fnm>E</fnm>
               <insr iid="I1"/>
               <insr iid="I2"/>
            </au>
            <au id="A2">
               <snm>Vuylsteke</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Downie</snm>
               <fnm>A</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A4">
               <snm>Dunning</snm>
               <fnm>JJ</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>McNeil</snm>
               <fnm>K</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A6">
               <snm>Menon</snm>
               <fnm>DK</fnm>
               <insr iid="I2"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Papworth Hospital, Cambridge, UK</p>
            </ins>
            <ins id="I2">
               <p>University of Cambridge, UK</p>
            </ins>
         </insg>
         <source>Critical Care</source>
         <supplement>
            <title>
               <p>18th Spring Meeting of the Association of Cardiothoracic Anaesthetists</p>
            </title>
            <sponsor>
               <note>Supported by an unrestricted educational grant from Bayer plc</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>18th Spring Meeting of the Association of Cardiothoracic Anaesthetists</p>
            </title>
            <location>Cambridge, UK</location>
            <date-range>22 June 2001</date-range>
         </conference>
         <issn>1364-8535</issn>
         <pubdate>2001</pubdate>
         <volume>5</volume>
         <issue>Suppl C</issue>
         <fpage>1</fpage>
         <xrefbib>
            <pubidlist>
               <pubid idtype="pmpid">15743460</pubid>
               <pubid idtype="doi">10.1186/cc1030</pubid>
            </pubidlist>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>3</day>
               <month>7</month>
               <year>2001</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2001</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <meta>
      <classifications>
         <classification type="BMC" subtype="old_arx_id">cc-5-4-236-01</classification>
      </classifications>
   </meta>
   <bdy>
      <sec>
         <st>
            <p>Introduction</p>
         </st>
         <p>It has been suggested that mild hypothermia during cardiopulmonary bypass (CPB) may attenuate, but not completely suppress, the production of interleukin-8 (IL-8) in the brain [<abbr bid="B1">1</abbr>]. This study examined the effect of repeated deep hypothermic circulatory arrest (DHCA) on production of IL-8 and myeloperoxidase (MPO) in the cerebrovascular bed in patients undergoing pulmonary thromboendarterectomy (PTE).</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>After LREC approval and written informed consent, we studied eight patients undergoing PTE. Anaesthetic and surgical technique were strictly standardized [<abbr bid="B2">2</abbr>] and all patients had a jugular bulb catheter inserted after induction. After initiation of CPB, all patients were cooled to below 20&#176;C and underwent at least two periods of DHCA for 20 min. Each DHCA period was separated by a 10-min reperfusion interval. The levels of IL-8 and MPO were measured in paired arterial and jugular samples drawn simultaneously at specific time points, using enzyme-linked immunoassay kits. Juguloarterial (j-a) gradients were then calculated. All data are expressed as median (interquartile range) and were compared with the baseline values using the Wilcoxon signed rank sum test. J-a gradients were compared with zero using one-sample <it>t</it>-test.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>The baseline arterial values before CPB [T1] for IL-8 and MPO were 12.9 (11.5-21.4)pg/ml and 4.5 (3.1-6.6)ng/ml, respectively (Fig. <figr fid="F1">1</figr>). For both IL-8 and MPO, arterial levels significantly increased before the first DHCA [T3] to 28.3 (21.6-43.1)pg/ml and 31.2 (26.1-11.7)ng/ml, respectively, and remained elevated until 8 min following the second DHCA [T7]. However, no significant j-a differences for IL-8 and MPO were found throughout this period.</p>
         <fig id="F1">
            <title>
               <p>Figure 1</p>
            </title>
            <caption>
               <p>IL-8 and MPO concentration during DHCA.</p>
            </caption>
            <text>
               <p>IL-8 and MPO concentration during DHCA. T1, postinduction; T2, CPB started; T3, 2 min preDHCA1; T4, 1 min postDHCA1; T5, 8 min postDHCA1; T6, 1 min postDHCA2; T7, 8 min postDHCA2. <sup>*</sup><it>P</it> &lt; 0.05 versus baseline.</p>
            </text>
            <graphic file="cc1030-1"/>
         </fig>
      </sec>
      <sec>
         <st>
            <p>Conclusions</p>
         </st>
         <p>These data imply that the cerebral activation of inflammatory processes represented as specific IL-8 and MPO production in the cerebrovascular bed are suppressed during repeated DHCA in the present study.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <aug>
               <au>
                  <snm>Nandate</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Vuylsteke</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Crosbie</snm>
                  <fnm>AE</fnm>
               </au>
               <etal/>
            </aug>
            <source>Anesth Analg</source>
            <pubdate>1999</pubdate>
            <volume>89</volume>
            <fpage>823</fpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1097/00000539-199910000-00003</pubid>
                  <pubid idtype="pmpid" link="fulltext">10512250</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>Anaesthesia for Pulmonary Endarterectomy.</p>
            </title>
            <aug>
               <au>
                  <snm>Wilson</snm>
                  <fnm>WC</fnm>
               </au>
               <au>
                  <snm>Vuylsteke</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>In Thoracic Anaesthesia. Edited by Ghosh S, Latimer RD. Oxford: Butterworth &amp; Heinemann;</source>
            <pubdate>1999</pubdate>
            <fpage>223</fpage>
            <lpage>234</lpage>
         </bibl>
      </refgrp>
   </bm>
</art>
